COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

Scientists at Sanofi, a global healthcare company, are inspired by the wonder of the natural world and are working to figure ...

Based in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a leading biotechnology company that develops messenger RNA (mRNA) ...

The company presented data showing that a single IV dose of its ctLNP delivered mRNA encoding a reporter protein to a ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

In last week’s column, I told you how the 2024 General Election (early voting has started) could lead to healthier, smarter, and longer lives for all of us (see: ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

TD Cowen analyst Tyler Van Buren has maintained their neutral stance on MRNA stock, giving a Hold rating on October 17. Tyler Van ...